Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naive non-small cell lung cancer
TUMORI, vol.99, no.4, pp.463-468, 2013 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 99 Issue: 4
- Publication Date: 2013
- Doi Number: 10.1177/030089161309900404
- Journal Name: TUMORI
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.463-468
- Keywords: advanced non-small cell lung cancer, triplet chemotherapy, gemcitabine, cisplatin, vinorelbine, COOPERATIVE ONCOLOGY GROUP, III RANDOMIZED-TRIAL, PHASE-II, COMBINATION, PACLITAXEL, REGIMENS, EFFICACY
- Acibadem Mehmet Ali Aydinlar University Affiliated: No
Abstract
Aims and background. To investigate the efficacy and tolerability of biweekly scheduled triplet chemotherapy consisting of gemcitabine, cisplatin and vinorelbine for chemotherapy-naive advanced non-small cell lung cancer.